<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Multidisciplinary Cancer Investigation</title>
<title_fa>نشریه بین المللی چند تخصصی سرطان</title_fa>
<short_title>Multidiscip Cancer Investig</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mcijournal.com</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2476-4922</journal_id_issn>
<journal_id_issn_online>2538-1911</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/mci</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1404</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2025</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<volume>0</volume>
<number>Multidisciplinary Cancer Investigation</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Oncometabolites: The Metabolic Shadow of Oncogenes</title>
	<subject_fa></subject_fa>
	<subject>Molecular Mechanisms</subject>
	<content_type_fa></content_type_fa>
	<content_type>Review Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:120%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span style=&quot;line-height:120%&quot;&gt;&lt;span style=&quot;color:#231f20&quot;&gt;Oncometabolites such as L-lactate, succinate, fumarate, R-2-hydroxyglutarate, kynurenine, and itaconate are emerging as pivotal drivers of cancer progression. Beyond their metabolic roles, these molecules function as signaling mediators that remodel epigenetic landscapes, reprogram the tumor microenvironment, and promote immune evasion. This review synthesizes current insights into their biochemical origins, oncogenic mechanisms, and therapeutic potential, highlighting how targeting oncometabolite-driven pathways could facilitate the development of novel cancer therapies.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span style=&quot;line-height:120%&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abstract>
	<keyword_fa>Oncometabolites, L-lactate, Succinate, Fumarate, R-2-Hydroxyglutarate, Kynurenine, Iltaconate</keyword_fa>
	<keyword>Fumarate,Iltaconate,Kynurenine,L-lactate,Oncometabolites,R-2-Hydroxyglutarate,Succinate,</keyword>
	<start_page>31</start_page>
	<end_page>46</end_page>
	<web_url>http://mcijournal.com/browse.php?a_code=A-10-721-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Zahra</first_name>
	<middle_name></middle_name>
	<last_name>Sheikhi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846004245</code>
	<orcid>10031947532846004245</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Integrative Oncology Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohtaram </first_name>
	<middle_name></middle_name>
	<last_name>Vafakhah</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846004246</code>
	<orcid>10031947532846004246</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hamed </first_name>
	<middle_name></middle_name>
	<last_name>Mirzaei</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846004247</code>
	<orcid>10031947532846004247</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mahdieh </first_name>
	<middle_name></middle_name>
	<last_name>Khosravi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846004248</code>
	<orcid>10031947532846004248</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Kambiz</first_name>
	<middle_name></middle_name>
	<last_name>Gilany</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>k.gilany@avicenna.ac.ir</email>
	<code>10031947532846004249</code>
	<orcid>10031947532846004249</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Integrative Oncology Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
